Global Left Atrial Appendage Closure Market 2017-2021

  • ID: 4032397
  • Report
  • Region: Global
  • 115 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AtriCure
  • Boston Scientific
  • Coherex Medical
  • Lifetech Scientific
  • Occlutech
  • SentreHEART
  • MORE
About Left Atrial Appendage Closure

Atrial fibrillation is one of the most common types of arrhythmia and is characterized by fast and irregular heart rhythms. The atria of patients suffering from the disease do not function properly. Atrial fibrillation can cause chest pain, heart failure, or stroke. The doctor needs to identify the first detected event of atrial fibrillation in a patient. The occurrence of two or more events of atrial fibrillation results in it being considered recurrent. In paroxysmal atrial fibrillation, the arrhythmia ends spontaneously, whereas in persistent atrial fibrillation the arrhythmia continues for more than a week.

Analysts forecast the global left atrial appendage closure market to grow at a CAGR of 33.54% during the period 2017-2021.

Covered in this Report:

The report covers the present scenario and the growth prospects of the global left atrial appendage closure market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sale of medical devices required for left atrial appendage closure.

The Market is Divided Into the Following Segments Based on Geography:

Americas
APAC
EMEA

Global Left Atrial Appendage Closure Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.

The report also includes a a discussion of the key vendors operating in this market.

Key Vendors:

AtriCure
Boston Scientific
Coherex Medical
St. Jude Medical

Other Prominent Vendors:

Occlutech
Lifetech Scientific
SentreHEART
Market Drivers:

Increasing incidences of atrial fibrillation
For a full, detailed list, view the full report

Market Challenges:

Increasing product recalls hindering growth prospects
For a full, detailed list, view the full report

Market Trends:

Emergence of 3D printing technology
For a full, detailed list, view the full report

Key Questions Answered in this Report:
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AtriCure
  • Boston Scientific
  • Coherex Medical
  • Lifetech Scientific
  • Occlutech
  • SentreHEART
  • MORE
Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction
Key market highlights
Atrial fibrillation
LAA closure devices

Part 05: Market landscape
Market overview
Five forces analysis

Part 06: Pipeline analysis

Part 07: Clinical trials

Part 08: Regulation of LAA closure devices

Part 09: Market segmentation by product type
Epicardial LAA closure device
Endocardial LAA closure device

Part 10: Market segmentation by end-user
Hospitals
ASCs
Heart clinics

Part 11: Geographical segmentation
LAA closure market in Americas
LAA closure market in EMEA
LAA closure market in APAC

Part 12: Market drivers
Increasing incidences of atrial fibrillation
Growing product approvals fueling market growth
Potential long-term cost-effectiveness associated with use of LAA closure devices
Shift from open to MI surgeries

Part 13: Impact of drivers

Part 14: Market challenges
Increasing product recalls hindering growth prospects
High acceptance of warfarin and dabigatran
Stringent regulatory environment affecting product approvals
Complications associated with LAA closure procedures

Part 15: Impact of drivers and challenges

Part 16: Market trends
Emergence of 3D printing technology
Emergence of hybrid approach in LAA closure techniques
Growing focus on clinical trials
Rising inorganic growth strategies

Part 17: Vendor landscape
Competitive scenario
Key news
M&A

Part 18: Key vendor analysis
AtriCure
Boston Scientific
Coherex Medical2
St. Jude Medical6
Other prominent vendors2

Part 19: Appendix3
List of abbreviations3

Part 20: Extras4
List of Exhibits
Exhibit 01: Snapshot of LAA closure market in 2016
Exhibit 02: Factors affecting LAA closure market
Exhibit 03: Snapshot of global LAA closure market
Exhibit 04: Timeline chart representing the approvals for LAA closure devices
Exhibit 05: Factors driving demand for LAA closure devices
Exhibit 06: Global LAA closure market 2016-2021 ($ millions)
Exhibit 07: Opportunity analysis of global LAA closure market
Exhibit 08: Five forces analysis
Exhibit 09: Snapshot of regulation of medical devices
Exhibit 10: Timeline of key events - WATCHMAN device regulations
Exhibit 11: Global LAA closure devices market segmentation by product type
Exhibit 12: Global LAA closure market segmentation by product type 2016 and 2021 (%)
Exhibit 13: Lifecycle analysis of global LAA closure market by product type
Exhibit 14: Global LAA closure market segmentation by product type 2016: Lifecycle analysis
Exhibit 15: Epicardial and endocardial LAA closure classification
Exhibit 16: Global LAA closure market segmentation by product type analysis
Exhibit 17: Highlights of endocardial LAA closure market
Exhibit 18: Global epicardial LAA closure market 2016-2021 ($ millions)
Exhibit 19: Highlights of endocardial LAA closure market
Exhibit 20: Global endocardial LAA closure market 2016-2021 ($ millions)
Exhibit 21: Global LAA closure market segmentation by product type 2016-2021 ($ millions)
Exhibit 22: Global LAA closure market segmentation by product type 2016-2021 (%)
Exhibit 23: Global LAA closure market segmentation by end-user 2016
Exhibit 24: Global LAA closure market segmentation by geography 2016 and 2021 (%)
Exhibit 25: Global LAA closure market segmentation by geography 2016: Analysis
Exhibit 26: Market growth lifecycle analysis of global LAA closure devices by geography
Exhibit 27: Market overview: Americas
Exhibit 28: LAA closure devices approvals until 2016 in Americas
Exhibit 29: LAA closure market in Americas 2016-2021 ($ millions)
Exhibit 30: Market overview: EMEA
Exhibit 31: LAA closure market in EMEA 2016-2021 ($ millions)
Exhibit 32: Product approvals in EMEA until 2016
Exhibit 33: Market overview: APAC
Exhibit 34: LAA closure market in APAC 2016-2021 ($ millions)
Exhibit 35: Global LAA closure market segmentation by geography 2016-2021 ($ millions)
Exhibit 36: Global LAA closure market segmentation by geography 2016-2021 (%)
Exhibit 37: Incidences of atrial fibrillation
Exhibit 38: Key product approvals
Exhibit 39: Key takeaways associated with cost-effectiveness of LAA closure devices
Exhibit 40: Key factors fueling the adoption rates of LAA closure devices
Exhibit 41: Impact of drivers
Exhibit 42: Major product recalls
Exhibit 43: Key factors fueling the adoption of warfarin and dabigatran
Exhibit 44: Key factors hindering the product approvals
Exhibit 45: Complications involved in LAA closure devices
Exhibit 46: Impact of drivers and challenges
Exhibit 47: Key factors that will have a positive impact on the market growth
Exhibit 48: Emergence of hybrid approach in LAA closure
Exhibit 49: Ongoing clinical trials of LAA closure device
Exhibit 50: M&A
Exhibit 51: Market share analysis of vendors in LAA closure market 2016
Exhibit 52: Competitive structure analysis of global LAA closure market 2016
Exhibit 53: Market penetration of various manufacturers of global LAA closure market 2016
Exhibit 54: Strategic success factors of companies in global LAA closure market
Exhibit 55: Key highlights of AtriCure
Exhibit 56: AtriCure strength assessment
Exhibit 57: AtriCure strategy assessment
Exhibit 58: AtriCure: Opportunity assessment
Exhibit 59: Key highlights of Boston Scientific
Exhibit 60: Boston Scientific: Strength assessment
Exhibit 61: Boston Scientific: Strategy assessment
Exhibit 62: Boston Scientific: Opportunity assessment
Exhibit 63: Key highlights of Coherex Medical
Exhibit 64: Coherex Medical: Strength assessment
Exhibit 65: Coherex Medical: Strategy assessment
Exhibit 66: Coherex Medical: Opportunity assessment
Exhibit 67: Key highlights of St. Jude Medical
Exhibit 68: St. Jude Medical: Strength assessment
Exhibit 69: St. Jude Medical: Strategy assessment
Exhibit 70: St. Jude Medical: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AtriCure
  • Boston Scientific
  • Coherex Medical
  • Lifetech Scientific
  • Occlutech
  • SentreHEART
  • MORE
Global Left Atrial Appendage Closure Market 2017-2021

Key players in the global left atrial appendage closure market: AtriCure, Boston Scientific, Coherex Medical, and St. Jude Medical

Other Prominent Vendors in the market are: Occlutech, Lifetech Scientific, and SentreHEART

Commenting on the report, an analyst said: “The increasing clinical trials of research organizations and vendors will expand the application of LAA closure devices by driving the revenue in the market. For new product approval and fulfilled regulatory procedures, it is necessary to carry out clinical trials. Various universities and vendors sponsor this clinical trial. Vendors focus on such trials because positive or negative clinical results of long-term follow-up from trials have an impact on the market. For instance, Novosibirsk Research Institute Of Blood Circulation Pathology and Boston Scientific are conducting a phase II clinical trial to evaluate the safety concern issues of implantation of LAA closure. The process is compared to the standard antiplatelet therapy for the prevention of thromboembolic events and stent thrombosis in individuals with atrial fibrillation who underwent percutaneous coronary intervention.”

According to the report, the growing incidences of atrial fibrillation increase the demand for LAA closure devices. Atrial fibrillation is the most common type of heart arrhythmia in which the heart beats at a rapid and irregular pace. The irregular heart rhythm fluctuates the blood flow from the heart, causing blood to stagnate in the LAA, form clots, and increase the risk of stroke. There are some risk factors such as diabetes, cigarette smoking, obesity, and cardiovascular diseases that lead to atrial fibrillation. LAA closure devices play a pivotal role in managing stroke risk in atrial fibrillation patients. Among the many cardiovascular diseases, atrial fibrillation is a common risk factor, which leads to stroke in some individuals. The LAA closure device is used to close the appendage that occurs in the left atria and reduces the risk of stroke. LAA closure devices are minimally invasive, which offers a novel approach for atrial fibrillation treatment.

Further, the report states that rrugs are an alternative treatment option for LAA closure devices. Though these devices are more effective and safer than drugs, they are less preferred. LAA closure device costs are required only once, while costs for warfarin and dabigatran continue to accrue year over year. This factor compels the preference for warfarin and dabigatran by consumers. The drugs used to treat diseases are less invasive in nature. Also, warfarin and dabigatran are used for treatment instead of LAA closure devices, as only a few people are aware of LAA closure devices, and its implants have complicated procedures. Also, the introduction of improved drug delivery techniques and enhanced drug pipelines for the treatment of atrial fibrillation diseases restrict the market growth. Thus, the increased acceptance of warfarin and dabigatran will hamper the growth of the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • AtriCure
  • Boston Scientific
  • Coherex Medical
  • St. Jude Medical
  • Occlutech
  • Lifetech Scientific
  • SentreHEART
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll